COL17A1 and Parkinson disease: Immunoblotting using the BP180 ectodomain found BP autoantibodies in 29.2% of the Parkinson’s disease patients, whereas immunoblotting using the BP180 intracellular domain detected BP autoantibodies in 19.2% of the dementia patients.